Jazz Pharmaceuticals receives EU marketing authorisation for Sunosi for excessive daytime sleepiness in adults with narcolepsy or OSA

Jazz Pharmaceuticals has secured EU marketing authorisation for Sunosi for excessive daytime sleepiness in adults with narcolepsy or OSA (Credit: Bruno /Germany from Pixabay)